miRNA-150 downregulation promotes pertuzumab resistance in ovarian cancer cells via AKT activation
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miRNA-150 downregulation promotes pertuzumab resistance in ovarian cancer cells via AKT activation
Authors
Keywords
miR-150, Pertuzumab, Ovarian cancer, Drug resistance
Journal
ARCHIVES OF GYNECOLOGY AND OBSTETRICS
Volume 292, Issue 5, Pages 1109-1116
Publisher
Springer Nature
Online
2015-05-18
DOI
10.1007/s00404-015-3742-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- miR-150 influences B-cell receptor signaling in chronic lymphocytic leukemia by regulating expression of GAB1 and FOXP1
- (2014) M. Mraz et al. BLOOD
- PI3K and cancer: lessons, challenges and opportunities
- (2014) David A. Fruman et al. NATURE REVIEWS DRUG DISCOVERY
- MicroRNA-150 Predicts a Favorable Prognosis in Patients with Epithelial Ovarian Cancer, and Inhibits Cell Invasion and Metastasis by Suppressing Transcriptional Repressor ZEB1
- (2014) Minfei Jin et al. PLoS One
- Pertuzumab: Optimizing HER2 Blockade
- (2013) O. Metzger-Filho et al. CLINICAL CANCER RESEARCH
- The role of miR-150 in normal and malignant hematopoiesis
- (2013) Y He et al. ONCOGENE
- FOXO3 induces FOXO1-dependent autophagy by activating the AKT1 signaling pathway
- (2012) Jingyi Zhou et al. Autophagy
- Curcumin induces autophagy to protect vascular endothelial cell survival from oxidative stress damage
- (2012) Jing Han et al. Autophagy
- Trastuzumab and Pertuzumab Produce Changes in Morphology and Estrogen Receptor Signaling in Ovarian Cancer Xenografts Revealing New Treatment Strategies
- (2011) D. Faratian et al. CLINICAL CANCER RESEARCH
- HER2-amplified breast cancer: mechanisms of trastuzumab resistance and novel targeted therapies
- (2011) Devika Gajria et al. Expert Review of Anticancer Therapy
- Ovarian Cancer Development and Metastasis
- (2010) Ernst Lengyel AMERICAN JOURNAL OF PATHOLOGY
- FOXO1A Is a Target for HER2-Overexpressing Breast Tumors
- (2010) Y. Wu et al. CANCER RESEARCH
- Pertuzumab for the treatment of ovarian cancer
- (2010) Simon P Langdon et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Enhancement of paclitaxel-induced apoptosis in HER2-overexpressing human breast cancer cells by a pertuzumab mimetic peptide, HRAP
- (2010) Hiroo Nakajima et al. JOURNAL OF BIOSCIENCE AND BIOENGINEERING
- Suppression of HER2/HER3-Mediated Growth of Breast Cancer Cells with Combinations of GDC-0941 PI3K Inhibitor, Trastuzumab, and Pertuzumab
- (2009) E. Yao et al. CLINICAL CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now